Technological Center “NovaMedica Innotech” started its activities in April 2017 in Moscow. It is a 100% subsidiary of the pharmaceutical company NovaMedica (investment project of RUSNANO). The center was created to develop new drugs and pilot production of solid dosage forms in accordance with the GMP standards.
NovaMedica Innotech has a unique set of innovative technological platforms for the development and production of modern competitive and effective medicines. Specialists of the R&D Center of NovaMedica Innotech develop own original products and carry out a number of projects within contracts with Russian and foreign partners.
Due to the highly qualified staff, cooperation with leading global R&D centers and leaders in various segments of the pharmaceutical industry, NovaMedica Innotech is the center of competence transfer in the field of drug development in Russia in accordance with the best global practices of GLP, GMP.
![]() |
![]() |
![]() |
21 September 2023
September 21 is World Alzheimer's Day. NovaMedica supports this awareness raising campaign
21 September 2023
12 September 2023
AI-supported spectroscopy delivers superior pharmaceutical packaging QC
03 October 2023
Lymphoma maintenance therapy delivers promise in CTCL
03 October 2023
02 October 2023
The FAS implemented 864 new drug prices in 2022
02 October 2023